new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Immunex Corporation
Immunex Corporation_20100121
Immunex Corporation_20100128
  

Immunex Corporation patents

Recent patent applications related to Immunex Corporation. Immunex Corporation is listed as an Agent/Assignee. Note: Immunex Corporation may have other listings under different names/spellings. We're not affiliated with Immunex Corporation, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Immunex Corporation-related inventors




Date Immunex Corporation patents (updated weekly) - BOOKMARK this page
02/23/17Compositions comprising a p75 tumor necrosis factor receptor/ig fusion protein
12/29/16Methods to determine the presence of an antibody that binds modified human thymic stromal lymphopoietin (tslp)
09/10/15Modified human thymic stromal lymphopoietin
01/01/15Antibodies that inhibit tslp activity
12/25/14Polypeptide formulation
08/21/14Rank ligand polypeptides
07/31/14Soluble tumor necrosis factor receptor treatment of medical disorders
07/03/14Receptor activator of nf-kappab
06/26/14Method of inhibiting osteoclast activity
06/05/14Use of interleukin-4 antagonists and compositions thereof
04/03/14Modified human thymic stromal lymphopoietin
08/29/13Tweak receptor
08/29/13Antibodies that inhibit tslp activity
08/08/13Rank ligand polypeptides
06/27/13Soluble tumor necrosis factor receptor treatment of medical disorders
04/25/13Method of inhibiting osteoclast activity
04/18/13Tweak receptor
04/04/13B7l-1 polynucleotides
10/18/12Compositions and methods for treating cardiovascular disease
10/11/12Methods of using btl-ii proteins
07/12/12Receptor activator of nf-kappab
06/14/12Polypeptide formulation
05/31/12Soluble tumor necrosis factor receptor treatment of medical disorders
02/09/12Cell lines producing blocking antibodies to human rankl
11/17/11Ulbp antibodies
09/22/11Modified human thymic stromal lymphopoietin
08/18/11Receptor activator of nf kappa-b
06/16/11Soluble tumor necrosis factor receptor treatment of medical disorders
04/21/11Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof
04/14/11Method of inhibiting osteoclast activity
03/03/11Cell culture performance with betaine
02/03/11Acpl-related assays
02/03/11Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
01/27/11Tweak receptor
01/06/11Use of interleukin-4 antagonists and compositions thereof
12/30/10Methods of using btl-ii proteins
12/23/10Use of trail polypeptides to treat cancer
11/04/10Methods for treating rheumatoid arthritis using il-17 antagonists
11/04/10C-type lectin polypeptide, polynucleotide and methods of making and use thereof
10/21/10Antibodies that inhibit tslp activity
09/16/10Novel receptor that binds ctla-8
08/26/10Methods of treatment using ldcam
08/12/10Antibodies that bind interleukin-4 receptor
08/05/10Methods of use of the taci/taci-l interaction
07/29/10Il-18 receptors
07/22/10Tweak receptor
07/01/10Modified human thymic stromal lymphopoietin
07/01/10Antibodies that bind b7l-1
06/10/10Molecules designated b7l-1
04/08/10Polypeptide formulation
04/01/10Lir-9, a novel leukocyte immunoglobulin-like receptor
04/01/10Methods of treating inflammatory disorders of the lungs
03/18/10Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l
03/04/10Selection of cells expressing heteromeric polypeptides
02/25/10Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides
01/28/10Human ox2 receptors
01/21/10Antagonists of interleukin-15
12/31/09Ulbp antibodies
12/03/09Methods for treating il-18 mediated disorders
11/05/09Ul16 binding protein 4
11/05/09Methods of treating inflammation using il-17 antagonists
10/29/09Purified tnfr preparations
10/22/09Cd30 ligand
10/01/09Treating diseases mediated by metalloprotease-shed proteins
09/17/09Il-1 eta dna and polypeptides
Patent Packs
09/10/09Human b7 polypeptides
09/10/09Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
06/25/09Soluble tumor necrosis factor receptor treatment of medical disorders
06/18/09Molecules designated ldcam
06/04/09Btl-ii nucleic acids
05/28/09Tweak receptor
05/28/09Tweak receptor
05/21/09Methods for treating rheumatoid arthritis using il-17 antagonists
05/07/09Use of trail polypeptides to treat cancer
04/30/09Sigirr dna and polypeptides
04/23/09Use of interleukin-4 antagonists and compositions thereof
03/26/09Methods of use of the taci/taci-l interaction
03/19/09Dendritic cell stimulatory factor
03/12/09Methods of inhibiting interleukin-17 receptor
01/28/10Human ox2 receptors
Patent Packs
01/21/10Antagonists of interleukin-15







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Immunex Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Immunex Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';